If one of these companies sounds like you, you may want to talk to us about eCTD Readiness.
Company A: A medium-sized pharma ready to move from paper to outsourced eCTD, but doesn’t understand impact or best practices.
Company B: A small biotech about to produce a new IND. It needs to choose a publishing partner and understand what it needs to do to interact efficiently with that partner.
Company C: A pharma that's been using a publishing partner for several years and needs to decide whether to bring publishing in-house. If publishing moves in, the company needs to understand the impact on its people, processes and technology.
Company D has decided to bring publishing in-house, and needs to choose a tool, develop processes and train staff.
Although these companies are at different stages and making different decisions, there is a common thread:
- They need education on requirements and best practices to make sound decisions and develop comprehensive and realistic plans.
- Their in-house resources are unlikely to have the time and experience needed to proceed in an efficient manner
- They are all facing risk – and anticipating benefit.